Chronic hepatitis B: Virology, natural history, current management and a glimpse at future opportunities.
about
Review of Laboratory Tests used in Monitoring Hepatitis B Response to Pegylated Interferon and Nucleos(t)ide Analog TherapyAutophagy and microRNA in hepatitis B virus-related hepatocellular carcinomaSymbiotic chemo- and immuno-therapy for hepatitis B and C virusesThe clinical implications of hepatitis B virus genotypes and HBeAg in pediatricsFunction and Regulation of MicroRNAs and Their Potential as Biomarkers in Paediatric Liver DiseaseHepatitis B virus molecular biology and pathogenesisPhosphorylation-specific status of RNAi triggers in pharmacokinetic and biodistribution analysesA Review of Antiviral Use for the Treatment of Chronic Hepatitis B Virus Infection in Pregnant Women.Peg-Interferon Lambda Treatment Induces Robust Innate and Adaptive Immunity in Chronic Hepatitis B Patients.Immune Tolerant Chronic Hepatitis B: The Unrecognized RisksEditorial: Recent Advances in HBV and HCV ImmunologyHepatitis B virus reverse transcriptase - Target of current antiviral therapy and future drug development.Transcriptome-Wide Analysis of Hepatitis B Virus-Mediated Changes to Normal Hepatocyte Gene Expression.Prevalence of hepatitis B seromarkers and hepatitis C antibodies in blood donors in Basra, Iraq.Comprehensive review of telbivudine in pregnant women with chronic hepatitis B.Characteristics of CpG Islands and their quasispecies of full-length hepatitis B virus genomes from patients at different phases of infection.Evolving New Strategies for the Medical Management of Chronic Hepatitis B Virus Infection.Removal of Integrated Hepatitis B Virus DNA Using CRISPR-Cas9.Core protein: A pleiotropic keystone in the HBV lifecycle.HBV: Do I treat my immunotolerant patients?New therapies for chronic hepatitis B.Immune balance in Hepatitis B Infection: Present and Future Therapies.Novel targets for hepatitis B virus therapy.Nationwide overview of the distribution of hepatitis B virus genotypes in Brazil: a 1000-sample multicentre study.Tenofovir alafenamide for the treatment of chronic hepatitis B virus infection.New antivirals for the treatment of chronic hepatitis B.Tolerance and immunity to pathogens in early life: insights from HBV infection.HIV-hepatitis B virus co-infection: epidemiology, pathogenesis, and treatment.A Simple Noninvasive Index Can Predict Hepatocellular Carcinoma in Patients with Chronic Hepatitis B.A Molecular Breadboard: Removal and Replacement of Subunits in an Hepatitis B Virus Capsid.Hepatitis B surface antigen loss and sustained viral suppression in Asian chronic hepatitis B patients: A community-based real-world study.Cure Strategies for Hepatitis B Virus: The Promise of Immunotherapy.miR-370 suppresses HBV gene expression and replication by targeting nuclear factor IA.The Structural Biology of Hepatitis B Virus: Form and Function.Advancing the regulatory path on hepatitis B virus treatment and curative research: a stakeholders consultation.Switching to PegIFNα-2b leads to HBsAg loss in patients with low HBsAg levels and HBV DNA suppressed by NAs.Tenofovir alafenamide in the treatment of chronic hepatitis B: design, development, and place in therapy.New Viral and Immunological Targets for Hepatitis B Treatment and Cure: A Review.Hepatitis B virus core protein allosteric modulators can distort and disrupt intact capsids.Immunotherapy for Chronic Hepatitis B Virus Infection.
P2860
Q26740161-716A4804-027D-413C-A66A-FF8F587AFEF7Q26772338-5235B35F-4883-429A-B16D-0F76C39788A2Q27468956-018AA354-A12E-4B0E-AC78-DBC70829F503Q28073299-26485B4F-8708-49D3-9DD9-E8271E12D75CQ28073703-211F28D4-29AE-42F4-80B5-BD9D00D39467Q28818406-2D0FBD25-64FC-423E-ACCB-2FA741A3A811Q33554206-127BF819-42E0-48B0-951D-7E90A0B741B8Q33711399-4E37D409-A2CB-493F-ADB9-52A78DEE9DBAQ33734554-7D56ECF5-446A-49E7-8B5E-D05E31C784A9Q33753902-14501529-FA9F-4A28-BC2A-671437B84BBEQ36026117-6948CA17-E5CC-41FA-96C2-40D376B6BE2CQ36264766-3DD566E1-0BCC-418C-9381-70F81A807B98Q36593582-D3D2879D-9A0F-4FC4-8017-D71D3722B883Q36662183-A9060BD5-E23D-42F2-A8E2-7045C0632E93Q36727510-88E33793-B227-47B7-A049-0543BCAD30F5Q37273204-871A97C3-E299-4D46-BB46-33E815975871Q37540212-E796ADA2-49BA-47DA-8964-DE1D15B630BAQ37714431-38D1731F-92BD-440C-A1B9-0FF13853D137Q38541052-E6D75B7F-C35F-4CCF-80DD-1FDCE9831CD9Q38685592-7749687F-F7AC-443E-B519-BD71BB9A76E4Q38725759-FC973FFE-820A-4191-AD6E-C10C099038FFQ38733622-189341AE-111D-4D4C-A504-AFD70B5C2D62Q39067316-3C60B5DD-E7C7-4174-BE4C-6C06BD4DAF09Q39158784-02BEBC05-5BE2-430A-AF04-E43AB83DED85Q39275759-557403EA-924E-4AF1-A9E1-A330A26C2CB6Q39315990-ED8537D3-3EF0-459C-99C2-CDF8BCA327A5Q39419957-A17D1080-DD6C-4E86-8C18-6D9A84CFA3C6Q39425755-7E2A6F27-901E-482F-A5A0-649E585D54E9Q40084991-70C6DA68-3300-421E-BF61-AD953ED0A3CAQ40088212-74A37A0A-1092-4C88-A596-F0C28A07EF87Q40172735-AD2BF798-65B5-417A-827D-53366FD3399AQ40306554-C6946699-E1FF-4C3B-94A3-A979C405EA3AQ40528642-60F465DA-8F2C-499C-93AD-9505D5D44C6BQ42048428-0973E7A0-74BF-4783-810F-C54BF7BC8593Q42318295-2409475C-4F39-4932-834B-3EA15BD0B562Q42683825-C0E3B2C0-2F19-4B86-906E-4F9CAAD79AC5Q47142298-C7355473-3358-46EE-88FE-3CB86C78579EQ47296036-64F175C4-60D1-4BB1-B2EE-E474387CD692Q47548307-915E24B2-7D83-463D-9F43-5C13CB84F7DAQ47556416-13346A72-6341-440F-9600-DDAD3E6B908E
P2860
Chronic hepatitis B: Virology, natural history, current management and a glimpse at future opportunities.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Chronic hepatitis B: Virology, ...... impse at future opportunities.
@en
type
label
Chronic hepatitis B: Virology, ...... impse at future opportunities.
@en
prefLabel
Chronic hepatitis B: Virology, ...... impse at future opportunities.
@en
P2093
P1433
P1476
Chronic hepatitis B: Virology, ...... impse at future opportunities.
@en
P2093
Bruce D Given
David L Lewis
Johnson Y N Lau
Stephen A Locarnini
Thomas Schluep
P356
10.1016/J.ANTIVIRAL.2015.06.008
P577
2015-06-16T00:00:00Z